LOS ANGELES, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 23, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Flywire Corporation ("Flywire" or the "Company") (NASDAQ: FLYW) securities between February 28, 2024 and February 25, 2025, inclusive (the "Class Period"). IF YOU SUFFERED A LOSS ON YOUR FLYWIRE INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING C ...

诉讼背景 - 沙尔律师事务所代表股东对Lineage公司提起集体诉讼 指控其违反联邦证券法 [1] - 诉讼针对2024年7月IPO期间依据发行文件购买公司证券的投资者 [2] - 股东需在2025年9月30日前联系律师事务所 [2] 指控内容 - 公司被指控在市场上发布虚假和误导性声明 [4] - 客户因去库存化及适应消费趋势变化导致需求疲软 [4] - IPO前以不可持续的方式提高产品价格 [4] - 未能通过营销或竞争优势应对需求问题 [4] 影响范围 - 市场了解公司真实情况后投资者遭受损失 [4] - 诉讼类别尚未获得认证 未采取行动的股东将作为缺席成员参与 [3]

WHAT'S NEXT? If you suffered a loss in XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP during the relevant time frame, you have until September 8, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate. NEW YORK, Aug. 5, 2025 /P ...

NEW YORK, Aug. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Flywire Corporation ("Flywire Corporation" or the "Company") (NASDAQ: FLYW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Flywire Corporation investors who were adversely affected by alleged securities fraud between February 28, 2024 and February 25, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/f ...

NEW YORK, Aug. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ("Replimune Group, Inc." or the "Company") (NASDAQ: REPL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Replimune Group, Inc. investors who were adversely affected by alleged securities fraud between November 22, 2024 and July 21, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1 ...

诉讼核心信息 - 律师事务所Levi & Korsinsky, LLP就Neogen Corporation（NASDAQ: NEOG）的证券集体诉讼通知投资者 [1] - 该诉讼旨在为在2023年1月5日至2025年6月3日期间因涉嫌证券欺诈而遭受不利影响的投资者挽回损失 [1] - 投资者可在2025年9月16日前请求法院指定其为首席原告 [3] 诉讼指控细节 - 指控称被告发布了一系列重大虚假和误导性陈述，让投资者相信公司与3M公司食品安全部门的整合进展比实际情况要好 [2] - 即使在公司被迫披露整合中出现某些“低效率”问题时，被告仍淡化问题并向投资者保证他们已充分了解并承诺迅速解决 [2] 律所背景 - Levi & Korsinsky律师事务所在过去20年间已为受损股东争取到数亿美元赔偿，并拥有赢得高风险案件的记录 [4] - 该律所在复杂证券诉讼中代表投资者方面拥有广泛专业知识，拥有超过70名员工的团队 [4] - 连续七年被ISS证券集体诉讼服务评为美国顶级证券诉讼律所之一 [4]

诉讼背景 - Levi & Korsinsky律所针对PepGen Inc（NASDAQ: PEPG）投资者发起证券集体诉讼，旨在为2024年3月7日至2025年3月3日期间因涉嫌证券欺诈遭受损失的投资者追回损失 [1] 指控内容 - 公司主打候选产品PGN-EDO51的实际有效性和安全性低于管理层向投资者传达的水平 [2] - 第二阶段CONNECT2研究存在设计缺陷或安全隐患，可能无法满足美国食品药品监督管理局（FDA）的批准要求 [2] - 上述问题导致公司可能中止CONNECT2研究，且PGN-EDO51的临床、监管及商业前景被夸大 [2] - 公司公开声明在诉讼期间存在重大虚假和误导性内容 [2] 程序安排 - 受影响投资者需在2025年8月8日前向法院申请作为首席原告 [3] - 参与赔偿无需支付任何自付费用，且无需承担首席原告职责 [3] 律所资质 - Levi & Korsinsky过去20年为股东追回数亿美元损失，拥有70人以上专业团队 [4] - 连续七年被ISS证券集体诉讼服务评为美国前50大证券诉讼律所 [4]

https://zlk.com/pslra-1/lockheed-martin-corporation-lawsuit-submission-form?prid=159580&wire=4 LMT investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) Lockheed Martin lacked effective internal controls regarding its purportedly risk adjusted contracts including the reporting of its risk adjusted profit booking rate; (2) Lockheed Martin lacke ...

NEW YORK, Aug. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Sable Offshore Corp. ("Sable Offshore Corp." or the "Company") (NYSE: SOC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Sable Offshore Corp. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of persons or entities who purchased or otherwise acquired publicly traded Sable Offshore securities between May 19, 2025 and June 3, 2 ...

诉讼概述 - Levi & Korsinsky律师事务所通知Alto Neuroscience Inc (NYSE: ANRO)的投资者有关一项证券集体诉讼[1] - 该诉讼旨在为因涉嫌证券欺诈而遭受损失的投资者挽回损失[2] 集体范围 - 集体包括所有在2024年2月2日左右公司首次公开募股中根据招股说明书购买或收购Alto普通股的个人和实体[2] - 集体也包括在2024年2月2日至2024年10月22日期间（含首尾两日）购买或收购Alto证券的所有个人和实体[2] 指控内容 - 指控称被告做出虚假陈述和/或隐瞒事实，即公司产品管线ALTO-100在治疗重度抑郁症方面的效果不如被告向投资者所宣称的那样有效[3] - 因此，ALTO-100的临床、监管和商业前景被夸大[3] - 结果导致Alto的业务和/或财务前景被夸大[3] - 公司公开声明在所有相关时间都存在重大虚假和误导性[3] 后续步骤 - 在相关时间段内遭受损失的投资者可在2025年9月19日前请求法院指定其为首席原告[4] - 作为集体成员，可能有资格获得补偿而无需支付任何自付费用[4]